Table 3.
Volunteer (gender) | No. of Days of Observation | Strain | Dose (CFUs) | No. of Initial Papules | No. of Pustules | Final Outcome of Sites |
||
---|---|---|---|---|---|---|---|---|
Papule | Pustule | Resolved | ||||||
387 (female) | 6 | P | 66 | 3 | 1 | 1 | 2 | |
M | 67–267 | 0 | 0 | 3 | ||||
388 (male) | 6 | P | 66 | 3 | 3 | 3 | ||
M | 67–267 | 3 | 1 | 1b | 2 | |||
390 (male) | 6 | P | 66 | 3 | 3 | 3 | ||
M | 67–267 | 3 | 0 | 3 | ||||
391 (male) | 5 | P | 17 | 3 | 0 | 3 | ||
M | 144–577 | 3 | 0 | 3 | ||||
394 (male) | 6 | P | 17 | 2 | 1 | 1 | 1 | |
M | 144–577 | 2 | 0 | 2 |
Abbreviations: CFUs, colony-forming units; M, mutant strain 35000HPsapBC; P, parent strain 35000HP.
a Volunteers 387, 388, and 390 were inoculated in the first iteration. Volunteers 391 and 394 were inoculated in the second iteration.
b One pustule formed at the site inoculated with 267 CFUs.